Cargando…

The Effect of CpG-Oligodeoxynucleotides with Different Backbone Structures and 3' Hexameric Deoxyriboguanosine Run Conjugation on the Treatment of Asthma in Mice

CpG-Oligodeoxynucleotide (ODN) has two backbones. Phosphorothioate backbone (PS) shows a strong immunostimulating effect while phosphodiester (PE) shows little in vivo. 3' hexameric deoxyriboguanosine-run (3' dG(6)-run) conjugation to PE CpG-ODN has been reported to enhance immunostimulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Yoon-Seok, Kim, Yoon-Keun, Kwon, Hyouk-Soo, Park, Heung-Woo, Min, Kyung-Up, Kim, You-Young, Cho, Sang-Heon
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752769/ https://www.ncbi.nlm.nih.gov/pubmed/19794984 http://dx.doi.org/10.3346/jkms.2009.24.5.860

Ejemplares similares

CpG oligodeoxynucleotides as mucosal adjuvants
por: Iho, Sumiko, et al.
Publicado: (2015)

Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2017)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Publisher Correction: Phosphodiester backbone of the CpG motif within immunostimulatory oligodeoxynucleotides augments activation of Toll-like receptor 9
por: Pohar, Jelka, et al.
Publicado: (2018)

Neonate Intestinal Immune Response to CpG Oligodeoxynucleotide Stimulation
por: Lacroix-Lamandé, Sonia, et al.
Publicado: (2009)

Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system
por: Hanagata, Nobutaka
Publicado: (2012)

CpG Oligodeoxynucleotides Inhibit RANKL-Induced Osteoclast Formation by Upregulating A20 Deubiquitinase in RAW 264.7 Cells
por: Kim, Seong-Kyu, et al.
Publicado: (2022)

Cooperative Stimulation of Dendritic Cells by Cryptococcus neoformans Mannoproteins and CpG Oligodeoxynucleotides
por: Dan, Jennifer M., et al.
Publicado: (2008)

CpG oligodeoxynucleotides potentiate the antitumor activity of anti-BST2 antibody
por: Hiramatsu, Kosuke, et al.
Publicado: (2015)

CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
por: Hanagata, Nobutaka
Publicado: (2017)

Synergistic oligodeoxynucleotide strongly promotes CpG-induced interleukin-6 production
por: Nigar, Shireen, et al.
Publicado: (2017)

A CpG oligodeoxynucleotide enhances the immune response to rabies vaccination in mice
por: Yu, Pengcheng, et al.
Publicado: (2018)

Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
por: Shirai, Seiki, et al.
Publicado: (2020)

CpG Oligodeoxynucleotides for Anticancer Monotherapy from Preclinical Stages to Clinical Trials
por: Zhang, Zhongkun, et al.
Publicado: (2021)

CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity
por: Chu, Rose S., et al.
Publicado: (1997)

CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury
por: Zhang, Chao, et al.
Publicado: (2013)

Effects of CpG oligodeoxynucleotide 1826 on acute radiation-induced lung injury in mice
por: Li, Xuan, et al.
Publicado: (2016)

Type II natural killer T cells foster the antitumor activity of CpG-oligodeoxynucleotides
por: Zhao, Jie, et al.
Publicado: (2014)

Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
por: Lai, Chao-Yang, et al.
Publicado: (2019)

Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice
por: Gao, Yuying, et al.
Publicado: (2020)

Anti-SARS-CoV immunity induced by a novel CpG oligodeoxynucleotide
por: Bao, Musheng, et al.
Publicado: (2006)

CpG oligodeoxynucleotides inhibit the proliferation and osteoclastic differentiation of RAW264.7 cells
por: Zheng, Yi, et al.
Publicado: (2020)

CpG oligodeoxynucleotides attenuate RORt-mediated Th17 response by restoring histone deacetylase-2 in cigarette smoke-exposure asthma
por: Li, Hongtao, et al.
Publicado: (2021)

CpG Oligodeoxynucleotide Inhibits Cockroach-Induced Asthma via Induction of IFN-γ(+) Th1 Cells or Foxp3(+) Regulatory T Cells in the Lung
por: Kim, Do-Hyun, et al.
Publicado: (2016)

Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers
por: Cooper, Curtis L, et al.
Publicado: (2008)

CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis
por: Hurtado, Plinio R, et al.
Publicado: (2008)

Intratracheal synthetic CpG oligodeoxynucleotide causes acute lung injury with systemic inflammatory response
por: Tasaka, Sadatomo, et al.
Publicado: (2009)

Development of CpG-Oligodeoxynucleotides for Effective Activation of Rabbit TLR9 Mediated Immune Responses
por: Chuang, Tsung-Hsien, et al.
Publicado: (2014)

Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines
por: Zhang, Huijie, et al.
Publicado: (2013)

The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
por: Yu, Wenwen, et al.
Publicado: (2020)

Structure-efficacy relationships of immunostimulatory activity of CpG-containing oligodeoxynucleotides on mouse spleen cells
por: Du, Hai-yan, et al.
Publicado: (2007)

Enhancement of the Immunostimulatory Effect of Phosphodiester CpG Oligodeoxynucleotides by an Antiparallel Guanine-Quadruplex Structural Scaffold
por: Safitri, Fika Ayu, et al.
Publicado: (2021)

Nuclease-resistant immunostimulatory phosphodiester CpG oligodeoxynucleotides as human Toll-like receptor 9 agonists
por: Meng, Wenjun, et al.
Publicado: (2011)

Systemic Administration of CpG Oligodeoxynucleotide and Levamisole as Adjuvants for Gene-Gun-Delivered Antitumor DNA Vaccines
por: Šmahel, Michal, et al.
Publicado: (2011)

The Effect of TLR9 Agonist CpG Oligodeoxynucleotides on the Intestinal Immune Response of Cobia (Rachycentron canadum)
por: Byadgi, Omkar, et al.
Publicado: (2014)

Intramuscular Administration of a Synthetic CpG-Oligodeoxynucleotide Modulates Functional Responses of Neutrophils of Neonatal Foals
por: Cohen, Noah D., et al.
Publicado: (2014)

PIKfyve Regulates the Endosomal Localization of CpG Oligodeoxynucleotides to Elicit TLR9-Dependent Cellular Responses
por: Hazeki, Kaoru, et al.
Publicado: (2013)

Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides
por: Zhang, Huijie, et al.
Publicado: (2015)

CpG Oligodeoxynucleotides Induce Differential Cytokine and Chemokine Gene Expression Profiles in Dapulian and Landrace Pigs
por: Hu, Jiaqing, et al.
Publicado: (2016)

CpG Oligodeoxynucleotides Downregulate Placental Adiponectin and Increase Embryo Loss in Non‐Obese Diabetic Mice
por: Qin, Chuan‐Mei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s06qdtpav2opim4bsjfg9k68b0